SEC Form 4 · accession 0000899243-19-002640
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Terrence Gibbs
Officer — General Counsel
Period of report
Nov 30, 2017
Accepted (ET)
Feb 5, 2019 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 30, 2017 | M | 6,500 | — | A | 50,687 | D | |
| Common StockF1 | Nov 30, 2018 | M | 6,500 | — | A | 57,187 | D | |
| Common StockF3 | Jan 31, 2019 | S | 939 | $3.35 | D | 56,248 | D | |
| Common StockF4 | Feb 1, 2019 | S | 1,820 | $3.47 | D | 54,428 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F5 | — | Nov 30, 2017 | M | 6,500 | D | — | — | Common Stock | 6,500 | 0 | D |
| Restricted Stock UnitsF1,F5 | — | Nov 30, 2018 | M | 6,500 | D | — | — | Common Stock | 6,500 | 0 | D |
Explanation of responses
- F1Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock.
- F2Includes 1,220 shares acquired under the Issuer's employee stock purchase plan on November 15, 2018.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.32 to $3.39. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.34 to $3.55. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5On November 30, 2016 the reporting person was granted 13,000 RSU's that vested in two equal annual installments beginning on November 30, 2017.